DanaherDHR
NYSE · USA · Segment 5 of 8 in the Medicine, pharma & life science value chain: Life science tools
American group focused on life science and diagnostics — bioprocessing (Cytiva), molecular diagnostics and laboratory solutions.
Life science tools: Instruments, reagents and equipment for research, development and production.
Key metrics
Market cap
$138B
Price
$198.95
Today
+1.5%
Return YTD
−14.4%
Return 1Y
−2.5%
P/E
37.3
P/S
5.6
P/B
2.6
Data as of 2026-07-10 · updates daily after U.S. close
Theme exposure
In the value chain
Products & services
- Bioprocessing (Cytiva)
- Molecular diagnostics (Cepheid)
- Life science instruments
Competitors
- Thermo Fisher
- Sartorius
- Agilent
Risks
- Cyclical bioprocessing demand
- Customer inventory normalisation
Same segment: Life science tools
See where Danaher sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →